- CEP-40783
-
- $93.00
-
2026-08-08
- CAS:1437321-24-8
- Purity: 99.76%
- Supply Ability: 10g
- CEP-40783
-
- $1.00
-
2019-12-25
- CAS:1437321-24-8
- Min. Order: 1KG
- Purity: 99%
|
| | CEP-40783 Basic information |
| Product Name: | CEP-40783 | | Synonyms: | CEP-40783;CEP-40783(RXDX-106);3-(4-fluorophenyl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid [4-(6,7-dimethoxyquinolin-4-yloxy)-3-fluorophenyl]amide;CEP 40783; CEP40783; RXDX-106;RXDX-106(CEP-40783);CS-2528;5-Pyrimidinecarboxamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]-3-fluorophenyl]-3-(4-fluorophenyl)-1,2,3,4-tetrahydro-1-(1-methylethyl)-2,4-dioxo-;N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)-3-fluorophenyl)-3-(4-fluorophenyl)-1-isopropyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide | | CAS: | 1437321-24-8 | | MF: | C31H26F2N4O6 | | MW: | 588.56 | | EINECS: | | | Product Categories: | | | Mol File: | 1437321-24-8.mol |  |
| | CEP-40783 Chemical Properties |
| density | 1.394±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMF:20.0(Max Conc. mg/mL);33.89(Max Conc. mM)
DMF:PBS (pH 7.2) (1:2):0.3(Max Conc. mg/mL);0.51(Max Conc. mM)
DMSO:6.04(Max Conc. mg/mL);10.26(Max Conc. mM)
Ethanol:2.0(Max Conc. mg/mL);3.4(Max Conc. mM) | | form | A crystalline solid | | pka | 10.42±0.70(Predicted) | | color | White to off-white | | InChIKey | FKCWHHYUMFGOPY-UHFFFAOYSA-N | | SMILES | C1(=O)N(C(C)C)C=C(C(NC2=CC=C(OC3C4C(N=CC=3)=CC(OC)=C(OC)C=4)C(F)=C2)=O)C(=O)N1C1=CC=C(F)C=C1 |
| | CEP-40783 Usage And Synthesis |
| Uses | CEP-40783 is a potent, selective and orally potent inhibitor of axl and c-Met with IC50 values of 7nM and 12nM, respectively. | | Biological Activity | RXDX-106 (CEP-40783) is an orally available, potent, and selective inhibitor of TAM (TYRO3, AXL, MER)/Met (c-Met), with low levels in peptide phosphorylation assays. Nanomolar biochemical activity; slow dissociation rate (T1/2 >120 min) in in vitro kinase binding assays. | | in vitro | CEP-40783 inhibited TAM and c-MET phosphorylation, accompanied by a decrease in downstream MAPK and PI3K signaling and cellular activity. In TAM-expressing cells, sub-nanomolar concentrations of RXDX-106 completely inhibited cell proliferation and cell viability. | | in vivo | CEP-40783 inhibits tumors with activating TAM gene fusions and affects the TAM-expressing tumor microenvironment, resulting in an overall anticancer environment. | | target | | Target | Value | Axl
(Cell-free assay) | 7 nM | c-Met
(Cell-free assay) | 12 nM | Tyro3
(Cell-free assay) | 19 nM | MER
(Cell-free assay) | 29 nM | Tyro3
(Cell-free assay) | 29 nM | | IC 50 | Axl |
| | CEP-40783 Preparation Products And Raw materials |
|
|
Tag:CEP-40783(1437321-24-8)
Related Product Information
|
|
LDC1267
CEP-32496 (free base)
CEP-28122
CEP-37440
Cabozantinib
AXL Protein, HUMAN (BIOTINYLATED, HEK293, HIS-AVI)
|
According to the laws, regulations and policies related to "patent products", the sale of this product is prohibited!
ChemicalBook prompt
The patent owner or licensee of the product has not released any relevant information for the time being.
|